General Information of Drug (ID: DMVCU5N)

Drug Name
PVX-2
Indication
Disease Entry ICD 11 Status REF
Human papillomavirus infection 1A9Y Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D8U2EM

References

1 ClinicalTrials.gov (NCT03911076) Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL (PVX-2). U.S. National Institutes of Health.